Medidata lands deals with Accenture and Biorasi

Medidata ($MDSO) has bolstered its books with two new deals. Accenture is tightening the ties between its R&D service offering and Medidata's Clinical Cloud and Rave EDC system. The deal expands a working relationship that dates back to 2002. Medidata also signed up CRO Biorasi as a partner. Biorasi is using Rave across its Phase I to IV clinical trials and is working toward adding ePRO and other tools. Release | More

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

The $58 million financing round represents biopharma industry's growing interest in genomics data.

Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.